Advisory Research Inc Simulations Plus, Inc. Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$34.96 - $43.94 $389,034 - $488,964	11,128 New	11,128 $488,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $731,768 - $1.02 Million	15,325 New	15,325 $744,000
Q4 2019 Feb 11, 2020	SELL	$29.07 - $35.63 $219,914 - $269,540	-7,565 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$28.19 - $41.75 $213,257 - $315,838	7,565 New	7,565 $263,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $582M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.